Since 2011, nearly 7,000 premature infants have been enrolled in the EPIPAGE 2 study. This study is aimed at assessing the survival of infants born between 22 and 34 weeks’ gestation, and their subsequent outcomes. Compared with data from the EPIPAGE 1 cohort in 1997, the proportion of infants born in 2011 from the 25th week of gestation, who survived without severe neonatal disease, showed a definite increase. However, survival is still rare for infants born before 25 weeks. These results make it possible to establish the prognosis for very premature and extremely premature infants, and review the changes that have occurred in the last 15 years. They provide useful information to medical teams caring for infants and supporting families.

This study, carried out by researchers from the Inserm EPOPé team—“Obstetrical, Perinatal, and Pediatric Epidemiology Team,” at the Epidemiology and Biostatistics Sorbonne Paris Cité Research Centre (CRESS, Inserm/Paris Descartes University Unit 1153)—is published in the journal JAMA Pediatrics.

http://presse-inserm.fr/en/survival-of-very-premature-infants-is-improving-in-france-first-results-of-the-epipage-2-study/17643/

Concerned neurodegenerative diseases are Alzheimer's disease and other dementias, Parkinson's disease and related diseases, prion diseases, motor neuron disease, Huntington's disease, cerebro-spinal ataxia and spinal muscular atrophy. Submitted projects must demonstrate added value of transnational cooperation and will include three to eight research teams from at least 3 countries participating in the PAA (list on the website of the ANR). Funding will be awarded for a period of three years. The ANR will fund only the French partners of the selected projects.

Deadline for applications: 10 March 2015

http://www.agence-nationale-recherche.fr/financer-votre-projet/documents/appel-detail0/appel-a-projets-de-recherche-europeens-sur-les-maladies-neurodegeneratives-facteurs-de-risque-et-de-protection-etudes-longitudinales-sur-cohortes-et-modeles-experimentaux-avances-jpcofund-2015-2015/

Inserm, the CPU and 7 research organizations signed a "national code of ethics of research work".

Universities, represented by the CPU (Conference of University Presidents), CNRS, INSERM, INRA, INRIA, IRD, CIRAD and the Institut Curie signed a "code of conduct of research occupations, "on Thursday, January 29, 2015 in Paris, during a seminar dedicated to scientific integrity. Developed by INSERM, the CPU, the CNRS and INRA, the charter aims to "clarify the criteria for good science and incorporates applicable particularly in the context of all national and international partnerships"

iCEPS conference

From 19 to 21 March 2015 in Montpellier (France) - Le Corum

Organizer: iCEPS

Thematic: non-drug interventional research

The conference is open to anyone interested in scientific, medical, social, legal and ethical posed by non-drug interventions.